PFIZER INC (PFE) Stock Fundamental Analysis
USA - NYSE:PFE - US7170811035 - Common Stock
24.665 USD
-0.19 (-0.74%)
PFE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. PFE scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on PFE. PFE also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year PFE was profitable.
In the past year PFE had a positive cash flow from operations.
In the past 5 years PFE has always been profitable.
PFE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.22%, PFE belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
With an excellent Return On Equity value of 12.12%, PFE belongs to the best of the industry, outperforming 87.96% of the companies in the same industry.
PFE's Return On Invested Capital of 8.54% is amongst the best of the industry. PFE outperforms 86.39% of its industry peers.
PFE had an Average Return On Invested Capital over the past 3 years of 11.29%. This is below the industry average of 15.45%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROIC | 8.54% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)11.29%
ROIC(5y)11.14%
1.3 Margins
PFE's Profit Margin of 16.84% is amongst the best of the industry. PFE outperforms 90.58% of its industry peers.
In the last couple of years the Profit Margin of PFE has declined.
PFE has a better Operating Margin (28.52%) than 93.19% of its industry peers.
In the last couple of years the Operating Margin of PFE has grown nicely.
Looking at the Gross Margin, with a value of 73.96%, PFE belongs to the top of the industry, outperforming 81.15% of the companies in the same industry.
In the last couple of years the Gross Margin of PFE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% |
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
2. Health
2.1 Basic Checks
PFE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
PFE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PFE has been increased compared to 5 years ago.
Compared to 1 year ago, PFE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.16 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.16, PFE is doing good in the industry, outperforming 65.44% of the companies in the same industry.
The Debt to FCF ratio of PFE is 4.97, which is a neutral value as it means it would take PFE, 4.97 years of fcf income to pay off all of its debts.
PFE has a better Debt to FCF ratio (4.97) than 82.72% of its industry peers.
PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating PFE is somewhat dependend on debt financing.
PFE's Debt to Equity ratio of 0.65 is on the low side compared to the rest of the industry. PFE is outperformed by 68.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Altman-Z | 2.16 |
ROIC/WACC1.03
WACC8.32%
2.3 Liquidity
PFE has a Current Ratio of 1.16. This is a normal value and indicates that PFE is financially healthy and should not expect problems in meeting its short term obligations.
PFE has a Current ratio of 1.16. This is in the lower half of the industry: PFE underperforms 79.06% of its industry peers.
PFE has a Quick Ratio of 1.16. This is a bad value and indicates that PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PFE (0.85) is worse than 80.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 151.11% over the past year.
PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
The Revenue has grown by 13.54% in the past year. This is quite good.
The Revenue has been growing by 9.10% on average over the past years. This is quite good.
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
3.2 Future
PFE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.74% yearly.
Based on estimates for the next years, PFE will show a decrease in Revenue. The Revenue will decrease by -2.93% on average per year.
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.74%
Revenue Next Year0.29%
Revenue Next 2Y-0.19%
Revenue Next 3Y-0.87%
Revenue Next 5Y-2.93%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.28 indicates a rather cheap valuation of PFE.
PFE's Price/Earnings ratio is rather cheap when compared to the industry. PFE is cheaper than 93.19% of the companies in the same industry.
PFE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
Based on the Price/Forward Earnings ratio of 7.69, the valuation of PFE can be described as very cheap.
PFE's Price/Forward Earnings ratio is rather cheap when compared to the industry. PFE is cheaper than 89.01% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PFE to the average of the S&P500 Index (23.23), we can say PFE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.28 | ||
| Fwd PE | 7.69 |
4.2 Price Multiples
92.67% of the companies in the same industry are more expensive than PFE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PFE is valued cheaper than 90.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.28 | ||
| EV/EBITDA | 7.13 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFE does not grow enough to justify the current Price/Earnings ratio.
PFE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)11.04
PEG (5Y)6.85
EPS Next 2Y1.57%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
PFE has a Yearly Dividend Yield of 7.01%, which is a nice return.
Compared to an average industry Dividend Yield of 6.88, PFE pays a better dividend. On top of this PFE pays more dividend than 98.95% of the companies listed in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
5.2 History
The dividend of PFE has a limited annual growth rate of 3.30%.
PFE has paid a dividend for at least 10 years, which is a reliable track record.
PFE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.3%
Div Incr Years14
Div Non Decr Years14
5.3 Sustainability
PFE pays out 89.68% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP89.68%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
NYSE:PFE (10/22/2025, 2:51:10 PM)
24.665
-0.19 (-0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners67.15%
Inst Owner Change-0.01%
Ins Owners0.02%
Ins Owner Change0%
Market Cap140.23B
Revenue(TTM)63.83B
Net Income(TTM)10.75B
Analysts71.33
Price Target29.9 (21.22%)
Short Float %1.99%
Short Ratio2.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
Yearly Dividend1.68
Dividend Growth(5Y)3.3%
DP89.68%
Div Incr Years14
Div Non Decr Years14
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.18%
Min EPS beat(2)32.91%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)43.14%
Min EPS beat(4)32.52%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)56.64%
EPS beat(12)12
Avg EPS beat(12)44.11%
EPS beat(16)16
Avg EPS beat(16)37.53%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)6.96%
Revenue beat(4)3
Avg Revenue beat(4)5.79%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.23%
Revenue beat(12)8
Avg Revenue beat(12)3.25%
Revenue beat(16)11
Avg Revenue beat(16)3.37%
PT rev (1m)0.64%
PT rev (3m)1.93%
EPS NQ rev (1m)-8.97%
EPS NQ rev (3m)-21.81%
EPS NY rev (1m)0.4%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.75%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.28 | ||
| Fwd PE | 7.69 | ||
| P/S | 2.2 | ||
| P/FCF | 11.28 | ||
| P/OCF | 9.23 | ||
| P/B | 1.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.13 |
EPS(TTM)3.39
EY13.74%
EPS(NY)3.21
Fwd EY13.01%
FCF(TTM)2.19
FCFY8.87%
OCF(TTM)2.67
OCFY10.83%
SpS11.23
BVpS15.6
TBVpS-5.8
PEG (NY)11.04
PEG (5Y)6.85
Graham Number34.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROCE | 10.81% | ||
| ROIC | 8.54% | ||
| ROICexc | 9.27% | ||
| ROICexgc | 42.97% | ||
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% | ||
| FCFM | 19.48% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)11.29%
ROIC(5y)11.14%
ROICexc(3y)12.95%
ROICexc(5y)13.16%
ROICexgc(3y)51.69%
ROICexgc(5y)47.96%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexgc growth 3Y-10.89%
ROICexgc growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score7
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 40.51% | ||
| Cap/Sales | 4.31% | ||
| Interest Coverage | 5.77 | ||
| Cash Conversion | 60.76% | ||
| Profit Quality | 115.66% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 2.16 |
F-Score7
WACC8.32%
ROIC/WACC1.03
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
EPS Next Y0.66%
EPS Next 2Y1.57%
EPS Next 3Y0.49%
EPS Next 5Y-4.74%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
Revenue Next Year0.29%
Revenue Next 2Y-0.19%
Revenue Next 3Y-0.87%
Revenue Next 5Y-2.93%
EBIT growth 1Y65.39%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year16.68%
EBIT Next 3Y5.82%
EBIT Next 5Y0.93%
FCF growth 1Y16.62%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y4.31%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%